NCT01490437View on ClinicalTrials.gov

Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Urothelial Carcinoma
Interventions
DRUG

Pemetrexed

Pemetrexed 500 mg/m2 IV over 10 minutes on D1 every 3 weeks

DRUG

Cisplatin

Cisplatin 70 mg/m2 IV over 60 minutes on D1 every 21 days

DRUG

Dexamethasone

Dexamethasone 4 mg bid PO from D-1 to D2 every 3 weeks

DRUG

Vitamins

Folic acid 350 ug - 600 ug daily from D-7 daily vitamin B12 1,000 ug every 9 weeks from D-7

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT01490437 - Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma | Biotech Hunter | Biotech Hunter